The Orphan Drug Act: New challenges and new opportunities

On November 28, 2018, Philip Katz and George A. O'Brien presented a complimentary webinar to discuss

  • the latest changes to the law, regulations, and Food and Drug Administration (FDA) policy;
  • the procedural and organizational changes brought about by the agency's Orphan Drug Modernization Plan; and
  • key issues of application to new technologies.

Watch (registration required): The Orphan Drug Act: New challenges and new opportunities


Back To Listing
Loading data